Drawing for VELI

USPTO serial 98039305

VELI

Reviewed by CopyMark Law Group

Reg. 8325954Status 700Registered
Filing date
Status date
Registration date
Jun 30, 2026
Examiner
PETTICAN, NATHANIEL VINCIENT
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with VELI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Antoinette G Giugliano

Antoinette G Giugliano ANTOINETTE G GIUGLIANO PC234 Causeway St, #1002BOSTON, MA 02114United States

Goods and services

ClassDescriptionStatusFirst use
005Clinical medical reagents, namely, a pre-treatment solution for use in plasma drying; Clinical medical reagents, namely, a reconstitution solution for use in hydration of dried plasma; Clinical medical reagents, namely, dried plasma; Clinical medical reagents in the nature of a filled bag having a pre-treatment plasma drying solution for medical and clinical use with plasma drying equipment; Clinical medical reagents in the nature of a filled bag having a reconstitution plasma drying solution for medical and clinical use with dried plasma; Clinical medical reagents in the nature of a filled bag having dried plasma for medical and clinical use; Clinical medical reagents in the nature of a filled bag having reconstituted plasma for medical and clinical useACTIVEDec 31, 2024
010Medical devices, namely, plasma drying equipment, filters for use with plasma drying equipment, and repair parts for plasma drying equipment; Medical devices, namely, plasma bag sealer and separator equipment, and repair parts for plasma bag sealer and separator equipment; Medical devices, namely, plasma drying disposable sets comprised of a nozzle and plasma drying chamber for drying plasma, plasma bags for the storage of plasma, and tubing sets comprised of medical tubing for use in connection with plasma drying equipment, and tubing sets comprised of medical tubing and a bag with a reconstitution solution and pretreatment solution for use in connection with plasma drying equipmentACTIVEDec 31, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 30, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 30, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 9, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jun 9, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jun 7, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 7, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 19, 2026IUAFUSE AMENDMENT FILED—
Feb 19, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 12, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 11, 2025EX2GSOU EXTENSION 2 GRANTED—
Aug 11, 2025EXT2SOU EXTENSION 2 FILED—
Aug 11, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 11, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 10, 2025EX1GSOU EXTENSION 1 GRANTED—
Feb 10, 2025EXT1SOU EXTENSION 1 FILED—
Feb 10, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 20, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 25, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 25, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 5, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 17, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 17, 2024XAECEXAMINER'S AMENDMENT ENTERED—
May 17, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 17, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
May 17, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
May 10, 2024ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 1, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 1, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 19, 2024PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 19, 2024PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 7, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 7, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Mar 7, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 7, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 7, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 1, 2024DOCKASSIGNED TO EXAMINER—
Jul 17, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 15, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance